Related Experiment Video

Updated: Mar 16, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.6K

Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells

Justyna Sosna1, Stephan Philipp2, Johaiber Fuchslocher Chico2

  • 1Institut für Immunologie, Christian-Albrechts-Universität zu Kiel, Kiel, Germany justyna.sosna@uksh.de.

Molecular and Cellular Biology
|August 17, 2016
PubMed

Insights

This study compares TRAIL- and TNF-mediated necroptosis, revealing shared and distinct signaling pathways. Understanding these differences offers unique targets for developing novel anticancer therapies.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Immunology

Background:

  • Regulated necrosis (RN), specifically necroptosis, is implicated in various pathophysiological processes.
  • Necroptosis presents an alternative strategy for eliminating cancer cells.
  • Limited research exists on TRAIL-mediated necroptosis components for anticancer applications.

Purpose of the Study:

  • To compare TRAIL-mediated necroptosis with TNF-mediated necroptosis.
  • To identify key molecular players and differences in their signaling pathways.
  • To explore potential therapeutic targets for cancer treatment.

Main Methods:

  • Comparative analysis of TRAIL- and TNF-mediated necroptosis signaling pathways.
  • Investigation of molecular components including sphingomyelinases, HtrA2/Omi, Atg5, vacuolar H(+)-ATPase, PARP-1, p38α, UCH-L1, and Atg16L1.
  • Assessment of mitochondrial involvement using Bcl-2 and Bcl-XL overexpression.
  • Evaluation of receptor internalization and endosome-lysosome acidification requirements.

Main Results:

  • Both TRAIL- and TNF-mediated necroptosis share signaling pathways involving sphingomyelinases, HtrA2/Omi, Atg5, and vacuolar H(+)-ATPase.
  • TRAIL- and TNF-induced necroptosis are independent of PARP-1; p38α depletion enhances both.
  • Key differences include the non-involvement of UCH-L1 and Atg16L1 in TRAIL-mediated necroptosis.
  • Mitochondrial proteins Bcl-2 and Bcl-XL differentially affect TRAIL- and TNF-induced necroptosis.
  • TRAIL-mediated necroptosis does not require receptor internalization or endosome-lysosome acidification.

Conclusions:

  • Distinct signaling pathways in TRAIL-mediated necroptosis, compared to TNF-mediated necroptosis, offer unique therapeutic targets.
  • Targeting these specific pathways could enhance necroptotic signaling for more precise tumor cell elimination.
  • This research provides a foundation for developing novel anticancer strategies leveraging necroptosis.

More Related Videos

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method16:07

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method

Published on: September 16, 2017

9.7K
Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

9.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K